Oliver Mortusewicz's Avatar

Oliver Mortusewicz

@mortusewicz

Principal Researcher @ Karolinska Institutet & Scilifelab. Interested in understanding molecular mechanism of DNA repair and targeting the DDR for cancer therapy Genome Stability | DNA replication | Cancer therapy

177
Followers
300
Following
8
Posts
14.11.2024
Joined
Posts Following

Latest posts by Oliver Mortusewicz @mortusewicz

Amazing work and truly inspiring!

22.05.2025 06:37 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Video thumbnail

New @nature.com
An ingenious way to track DNA replication patterns at the single-cell level that leads to cell heterogeneity and daughter cells that can potentially give rise to cancer
www.nature.com/articles/s41...

21.05.2025 17:17 πŸ‘ 228 πŸ” 45 πŸ’¬ 3 πŸ“Œ 3

Huge thanks to James Haslam, Helge Gad and Thomas Helleday! A special thanks also to the Molecular Cell @cp-molcell.bsky.social editorial team and the Reviewers for their invaluable feedback.

20.05.2025 08:07 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

πŸ”¬ We discuss:
- The origins of uracil in DNA and the cellular machinery dedicated to its repair.
- The intricate ways uracil-induced replication stress compromises genome integrity.
- Implications for designing and improving anti-cancer therapies, particularly those targeting nucleotide metabolism.

20.05.2025 08:07 πŸ‘ 0 πŸ” 1 πŸ’¬ 1 πŸ“Œ 0
Redirecting

πŸš€ Thrilled to share our latest review: "Uracil-induced replication stress drives mutations, genome instability, anti-cancer treatment efficacy, and resistance"

πŸ‘‰ doi.org/10.1016/j.mo...

#CancerResearch #DNARepair #ReplicationStress #MolecularCell #GenomicInstability #CancerTherapy #Uracil

20.05.2025 08:07 πŸ‘ 7 πŸ” 1 πŸ’¬ 2 πŸ“Œ 0
Conventional chemotherapy: millions of cures, unresolved therapeutic index

Article abstract
In recent decades, millions of patients with cancer have been cured by chemotherapy alone. By β€˜cure’, we mean that patients with cancers that would be fatal if left untreated receive a time-limited course of chemotherapy and their cancer disappears, never to return. In an era when hundreds of thousands of cancer genomes have been sequenced, a remarkable fact persists: in most patients who have been cured, we still do not fully understand the mechanisms underlying the therapeutic index by which the tumour cells are killed, but normal cells are somehow spared. In contrast, in more recent years, patients with cancer have benefited from targeted therapies that usually do not cure but whose mechanisms of therapeutic index are, at least superficially, understood. In this Perspective, we will explore the various and sometimes contradictory models that have attempted to explain why chemotherapy can cure some patients with cancer, and what gaps in our understanding of the therapeutic index of chemotherapy remain to be filled. We will summarize principles which have benefited curative conventional chemotherapy regimens in the past, principles which might be deployed in constructing combinations that include modern targeted therapies.

Conventional chemotherapy: millions of cures, unresolved therapeutic index Article abstract In recent decades, millions of patients with cancer have been cured by chemotherapy alone. By β€˜cure’, we mean that patients with cancers that would be fatal if left untreated receive a time-limited course of chemotherapy and their cancer disappears, never to return. In an era when hundreds of thousands of cancer genomes have been sequenced, a remarkable fact persists: in most patients who have been cured, we still do not fully understand the mechanisms underlying the therapeutic index by which the tumour cells are killed, but normal cells are somehow spared. In contrast, in more recent years, patients with cancer have benefited from targeted therapies that usually do not cure but whose mechanisms of therapeutic index are, at least superficially, understood. In this Perspective, we will explore the various and sometimes contradictory models that have attempted to explain why chemotherapy can cure some patients with cancer, and what gaps in our understanding of the therapeutic index of chemotherapy remain to be filled. We will summarize principles which have benefited curative conventional chemotherapy regimens in the past, principles which might be deployed in constructing combinations that include modern targeted therapies.

Great perspective on the importance of conventional chemotherapy.

Despite many many decades of successful use, do we understand how these drugs work?

www.nature.com/articles/s41...

18.12.2024 21:06 πŸ‘ 20 πŸ” 7 πŸ’¬ 2 πŸ“Œ 1
Preview
Cancer Research KI (CRKI) on LinkedIn: Blue Sky Research Grant Recipients Cancer Research KI (CRKI) would like to congratulate the ten recipients of the Blue Sky Grant for innovative cancer research in 2024: Kutter Claudia Erdinc…

www.linkedin.com/posts/cancer...

Thanks again for the support @CRKI!

17.12.2024 18:36 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Chromosomal instability as a driver of cancer progression - Nature Reviews Genetics Chromosomal instability (CIN) drives cancer progression through diverse mechanisms. The authors review the molecular consequences of CIN in advanced cancer, such as genomic and phenotypic heterogeneit...

www.nature.com/articles/s41...

13.12.2024 06:41 πŸ‘ 13 πŸ” 4 πŸ’¬ 0 πŸ“Œ 0

Thanks a lot Kumar! πŸ™

11.12.2024 19:21 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Very happy to have been able to contribute to this amazing story! Check out the paper at Nature Communications and the 🧡 by @nckvalerie.bsky.social below πŸ‘‡. We believe #CeTeam will be an invaluable tool for #drugdiscovery and #targetvalidation in #cells

πŸ”—: www.nature.com/articles/s41...

11.12.2024 19:20 πŸ‘ 4 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
Blue Sky Research Grant Recipients The Blue Sky Research Grant for Innovative Cancer Research is a one-year grant, providing SEK 500 000, to support an innovative pilot project aimed at demonstrating proof of principle. The project sho...

Couldn't have wished for a better first post here. I’m very happy and grateful to have received a #BlueSkyGrant from #KarolinskaInstitutet. This will allow us to validate the DNA Glycosylase #SMUG1 as a #target to exploit uracil toxicity in combination #therapy for colorectal #cancer.

11.12.2024 19:05 πŸ‘ 5 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0